×îÐÂÐÓ°ÉÔ­´´

The intersection of COVID-19 and substance use represents the confluence of two severe public health crises, with the COVID-19 pandemic compounding the ongoing opioid crisis. There is a clear increased risk of harm to people who use drugs or who have a substance use disorder in the COVID-19 context due to self-isolation requirements, physical distancing measures, and/or an increasingly toxic illegal drug supply.

This funding opportunity is composed of two key components, both representing critical evaluation needs that have been heightened by the COVID-19 pandemic: safer supply and SCS.

.

Deadlines

Application: November 12, 2020 at 9pm AST

Please notify Susan Haydt (susan.haydt@dal.ca) if you intend to apply for this opportunity.